Literature DB >> 3030945

Technetium-99m pyrophosphate single-photon emission computed tomography of the heart in familial amyloid polyneuropathy.

K Karp, U Näslund, C Backman, P Eriksson.   

Abstract

A patient with familial amyloid polyneuropathy and congestive heart failure underwent myocardial imaging using technetium-99m pyrophosphate. Planar scintigraphy showed an intense, diffuse biventricular uptake of the radiotracer. Single-photon emission computed tomography demonstrated an unevenly distributed uptake of the isotope. The greatest activity corresponded to regions with marked echocardiographic changes. Emission tomography may aid in assessing the degree and distribution of the infiltrative lesions in cardiac amyloidosis.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3030945     DOI： 10.1016/0167-5273(87)90209-9

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  4 in total

1.  Estimating cancer risk from 99mTc pyrophosphate imaging for transthyretin cardiac amyloidosis.

Authors:  Andrew J Einstein; Igor Shuryak; Adam Castaño; Akiva Mintz; Mathew S Maurer; Sabahat Bokhari
Journal:  J Nucl Cardiol       Date:  2018-05-30       Impact factor: 5.952

2.  Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis.

Authors:  Sabahat Bokhari; Rachelle Morgenstern; Richard Weinberg; Mona Kinkhabwala; Demetrios Panagiotou; Adam Castano; Albert DeLuca; Andrew Kontak; Zhezhen Jin; Mathew S Maurer
Journal:  J Nucl Cardiol       Date:  2016-08-31       Impact factor: 5.952

3.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

Review 4.  Nuclear imaging in cardiac amyloidosis.

Authors:  A W J M Glaudemans; R H J A Slart; C J Zeebregts; N C Veltman; R A Tio; B P C Hazenberg; R A J O Dierckx
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-21       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.